Mayinglong Pharmaceutical Group Co., Ltd.SSE: 600993

Announcement on Obtaining Drug Registration Certificate by Subsidiary

· Issued by Mayinglong Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Mayinglong Pharmaceutical Group Co., Ltd. announced that its subsidiary has obtained a drug registration certificate for a new eye medication.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Obtaining Drug Registration Certificate by Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Mayinglong Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Mayinglong Pharmaceutical

Later from Mayinglong Pharmaceutical

All Mayinglong Pharmaceutical news releases